Delayed AICD therapy and cardiac arrest resulting from undersensing of ventricular fibrillation in a subject with hypertrophic cardiomyopathy–A case report

• Main Authors: Ashley Chin, Jeffrey S. Healey, Carlos S. Ribas, Girish M. Nair
• Format: Article
• Language: English
• Published: Elsevier 2015-03-01
• Series: Indian Pacing and Electrophysiology Journal
• Subjects: Hypertrophic cardiomyopathy; Automatic implantable cardioverter defibrillator; Undersensing of ventricular fibrillation; Cardiac arrest
• Online Access: http://www.sciencedirect.com/science/article/pii/S0972629215000108
• ISSN: 0972-6292

Defibrillation testing is no longer routinely performed after automatic implantable cardioverter-defibrillator (AICD) implantation. However, certain subjects undergoing AICD implantation may be at higher risk of undersensing of ventricular arrhythmias resulting in potentially fatal outcomes. We present the case of a 30-year-old woman with hypertrophic cardiomyopathy (HCM; ‘asymmetric septal hypertophy’ morphologic variant) and prophylactic AICD who experienced an out of hospital cardiac arrest. AICD interrogation revealed undersensing as a result of intermittent high amplitude electrograms during an episode of ventricular fibrillation (VF). The subject underwent replacement and repositioning of the AICD lead along with pulse generator replacement (that utilized a different VF sensing algorithm) with appropriate sensing of VF and successful defibrillation testing. The presence of intermittent high amplitude electrograms during episodes of VF in AICDs using the AGC function should be recognized as a situation that may necessitate interventions to prevent undersensing and consequent delay in therapy.